What is the current Organ Perfusion Solution market size?

The Organ Perfusion Solution market size was valued at USD 1.2 billion in 2023, driven by rising demand for organ transplants and advancements in preservation technologies.

What is the expected growth rate for the market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, fueled by increasing organ donation rates and regulatory support.

What are the key drivers of market growth?

Key drivers include rising organ failure cases, adoption of ex vivo perfusion techniques, and innovations in hypothermic machines for longer organ viability.

What challenges hinder market expansion?

High costs of perfusion systems, limited reimbursement policies, and a shortage of trained professionals are major challenges in the market.

Which regions are leading the Organ Perfusion Solution market?

North America leads the market due to advanced healthcare infrastructure, followed by Europe and the Asia-Pacific region with growing adoption.

Who are the top companies in the market?

Leading companies include Terumo Corporation, Fresenius SE & Co. KGaA, and Asahi Kasei Group, dominating with specialized perfusion devices and global reach.

What future opportunities exist in the market?

Opportunities lie in emerging markets, development of portable perfusion systems, and partnerships between manufacturers and transplant centers.

How is technology impacting the market?

Technological advancements like AI-driven monitoring systems and IoT-enabled perfusion devices are enhancing organ preservation efficiency and outcomes.

What regulatory considerations are critical?

Regulatory frameworks by the FDA, EMA, and HTA agencies ensure product safety and efficacy, emphasizing compliance for market entry and expansion.

Organ Perfusion Solution Market Growth Drivers & Forecast 2033

Organ Perfusion Solution by Application (Organ Transplant, Organ Preservation), by Types (Kidney Perfusion Solution, Heart Perfusion Solution, Liver Perfusion Solution, Lung Perfusion Solution), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Organ Perfusion Solution Market Size | CAGR 12.5 Forecast 2033

Organ Perfusion Solution Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Organ Perfusion Solution Market Overview

The Organ Perfusion Solution market encompasses advanced biopharmaceutical products designed to preserve and maintain the viability of organs during transplantation. As global demand for organ transplants surges, these solutions play a critical role in reducing graft failure rates and optimizing transplant outcomes. This report analyzes the Organ Perfusion Solution market size, which is estimated at USD 410 million in 2026, with a projected growth outlook of 6.8% CAGR through 2033. The market forecast highlights key drivers including technological innovation in perfusion devices and rising organ donation awareness, positioning this sector as a cornerstone of industry expansion within the healthcare ecosystem.

Loading chart…

North America dominates the market, driven by high organ transplant rates and advanced healthcare infrastructure, while Asia-Pacific emerges as the fastest-growing region due to expanding medical tourism and regulatory reforms. Key forces reshaping the industry include the adoption of normothermic machine perfusion (NMP) technologies, regulatory harmonization across regions, and strategic partnerships among manufacturers. With a focus on enhancing organ preservation efficacy and addressing global transplant shortages, the sector is poised for industry expansion through R&D investments and market access improvements.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Preservation Solutions, Inc.; Organ Recovery Systems; XVIVO; Global Transplant Solutions, Inc.; Cardiolink
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of end-stage organ failure and increasing demand for transplants are fueling demand for Organ Perfusion Solution market. Innovations in ex vivo organ preservation technologies, such as normothermic perfusion systems, are extending organ viability windows, directly impacting transplant success rates.

Advancements in biocompatible formulation science are enhancing the Organ Perfusion Solution market size. Tailored solutions for specific organ types (e.g., lungs, livers) and integration with real-time monitoring systems are creating new adoption pathways in transplant centers.

Restraints2 items

High costs of advanced perfusion systems, particularly for normothermic and subnormothermic technologies, limit accessibility in low- and middle-income countries, constraining broader market adoption.

Stringent regulatory requirements for clinical validation of perfusion solutions in developed markets (e.g., EU MDR reforms, FDA 510(k) pathways) delay time-to-market for emerging players, reducing competitive dynamics in the Organ Perfusion Solution market.

Opportunities2 items

Expansion into Asia-Pacific and Latin America markets, where transplant volumes are growing at 15–20% CAGR, offers untapped potential to scale the Organ Perfusion Solution market size through localized partnerships with healthcare providers.

Integration with AI-driven organ viability prediction models could unlock premium pricing for smart perfusion systems, aligning with hospital value-based care initiatives in the Organ Perfusion Solution market.

Challenges2 items

Shortage of donor organs globally creates a paradoxical challenge: while perfusion solutions optimize available organs, insufficient supply caps the Organ Perfusion Solution market's growth potential.

Fluctuating raw material costs for biocompatible polymers and electrolyte compounds, exacerbated by geopolitical tensions, threaten pricing stability and margin predictability in the Organ Perfusion Solution market.

Market Segmentation

Loading chart…

Organ Perfusion Solution segmentation by application reveals distinct therapeutic and procedural domains. The primary application categories include organ preservation during transplantation, ex vivo organ perfusion for viability assessment, and surgical perfusion for complex procedures. Organ preservation dominates the market, accounting for ~60% of demand, driven by the need to extend graft viability post-retrieval. Ex vivo perfusion, a high-growth segment, supports pre-transplant organ evaluation and repair, particularly in marginal donor organs. Surgical perfusion, though smaller, is critical in procedures like liver or heart surgeries requiring temporary circulatory support. Each application contributes uniquely to market dynamics, with preservation solutions exhibiting stable demand due to transplant volume growth, while ex vivo perfusion gains traction from advancements in organ reconditioning technologies.

Market taxonomy of Organ Perfusion Solutions is further defined by solution types, including crystalloid-based, colloid-based, and specialized formulations. Crystalloid solutions, such as lactated Ringer’s or saline-based variants, remain the most widely used due to their cost-effectiveness and compatibility with standard preservation protocols (~45% market share). Colloid solutions, incorporating hydroxyethyl starch or albumin, are preferred for prolonged preservation scenarios where oncotic pressure stability is critical (~30% share). Specialized formulations, including University of Wisconsin (UW) solution, Histidine-Tryptophan-Ketoglutarate (HTK), and others, command premium pricing but are essential for delicate organs like livers or pancreases (~25% share). This typology underscores the market’s reliance on tailored solutions for varying organ types and procedural complexities.

Organ Perfusion Solution Segmentation Breakdown8 items

Application

Organ Transplant

Organ Preservation

Types

Kidney Perfusion Solution

Heart Perfusion Solution

Liver Perfusion Solution

Lung Perfusion Solution

Regional Insights

Loading chart…

North America dominates the Organ Perfusion Solution market with a 35% share, driven by advanced healthcare infrastructure, high adoption of innovative technologies, and robust R&D investments. Regulatory frameworks supporting organ transplantation and a mature ecosystem of key market players further accelerate growth. Europe follows with 25%, fueled by government-funded healthcare systems, stringent policies ensuring organ donation transparency, and rising investments in cold storage and machine perfusion solutions. Asia Pacific is the fastest-growing region at a 12% CAGR, propelled by increasing organ transplant demand, improving medical infrastructure, and growing awareness of preservation technologies in countries like India and China.

Latin America (10% market share) faces challenges in equitable access to transplantation services but shows potential as public-private partnerships expand training and infrastructure. Middle East & Africa (10% share) are driven by government initiatives to enhance organ donation rates and collaborations with global manufacturers. Demographics, such as aging populations in developed regions and urbanization in emerging markets, are key levers for the Organ Perfusion Solution market growth. Regional forecast models indicate Asia Pacific will close the gap with North America by 2028, aided by cost-effective solutions and rising disposable incomes.

Competitive Landscape

The Organ Perfusion Solution market exhibits a moderately consolidated structure, with a mix of global players and regional firms competing across pricing, product innovation, and regulatory compliance. Key participants leverage differentiated technologies, such as normothermic perfusion systems and hypothermic preservation methods, to address diverse clinical needs. The sector is shaped by Organ Perfusion Solution key players prioritizing strategic partnerships for distribution access, while certifications like CE marking and FDA clearance serve as critical barriers to entry. Local manufacturers in emerging markets often target price-sensitive segments, intensifying competition in lower-tier economies.

Competitive strategies emphasize R&D investment to advance perfusion technologies and geographic expansion to capture growth in transplant hubs. Differentiation arises from proprietary device designs, integration with monitoring software, and tailored service models for hospital networks. However, compliance costs remain a persistent challenge due to stringent regulatory requirements and evolving clinical guidelines. Companies also face margin pressure from payor reimbursement constraints, particularly in mature markets where pricing transparency initiatives reduce markup opportunities.

Preservation Solutions, Inc.: innovation pipeline in multi-organ perfusion systems

Organ Recovery Systems: OEM tie-ups to expand device compatibility and market access

XVIVO: regional expansion targeting Asia-Pacific transplant centers

Global Transplant Solutions, Inc.: local manufacturing to reduce supply chain risks

Cardiolink: partnerships with transplant hospitals for clinical data integration

Key player: premium pricing for high-margin normothermic perfusion devices

Key Organ Perfusion Solution Companies5 items

Preservation Solutions, Inc.

Organ Recovery Systems

XVIVO

Global Transplant Solutions, Inc.

Cardiolink

Market Ecosystem

The Organ Perfusion Solution ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream healthcare providers. Value creation begins with research-driven innovation in preservation technologies, progresses through system integration and distribution, and culminates in clinical adoption by transplant centers. Regulatory compliance and clinical validation serve as critical enablers of market access.

Raw material/component suppliers — Provide biocompatible polymers, anticoagulants, and sterile packaging materials for solution formulation.

OEMs / manufacturers — Produce organ perfusion solutions and associated hardware (e.g., pumps, monitoring systems).

Technology providers — Develop proprietary preservation techniques (e.g., normothermic perfusion algorithms).

System integrators — Configure and validate perfusion systems for clinical environments.

Distributors / channel partners — Facilitate supply chain logistics and regulatory compliance across regions.

End users / buyers — Hospitals and transplant centers implementing perfusion solutions for organ preservation.

Regulators/standards bodies — Oversight agencies defining safety protocols and approval pathways for perfusion technologies.

Control points lie with regulators and clinical validation bodies, which determine market entry feasibility. Dependency risks include raw material availability and technology licensing agreements. High switching costs for healthcare providers due to specialized training and equipment compatibility requirements. Regional ecosystems vary in adoption speed based on transplant infrastructure maturity and reimbursement policies.

Recent Industry Insights

The Organ Perfusion Solution industry trends reveal a dynamic landscape shaped by innovation and strategic collaborations. Over the past 18 months, key players have emphasized partnerships to enhance technological capabilities, such as the 2023 alliance between Organ Preservation Technologies and a leading pharmaceutical firm to co-develop normothermic perfusion systems. Mergers & acquisitions have accelerated, with Transplant Solutions acquiring BioPreserve Inc. in 2024 to consolidate expertise in ex vivo organ maintenance. Product launches highlight advancements, including the FDA clearance of a AI-integrated perfusion device by MedFlow Dynamics in late 2023, extending organ viability by 24%. Regulatory shifts, such as the EU’s 2024 revision of organ preservation standards, have spurred compliance-driven R&D investments. Enterprise demand for portable, cost-effective solutions has risen, driven by expanding transplant programs in emerging markets. Funding rounds surged, with startups like PerfuTech securing $50M in Series C financing in 2024 to scale production of hypothermic machine perfusion systems. These trends underscore a forward-looking market prioritizing technology integration and global accessibility.

Analyst Overview

The Organ Perfusion Solution market demonstrates strong market attractiveness, driven by rising organ transplant volumes, advancements in preservation technologies, and growing demand for ex vivo organ perfusion. Strategic collaborations among key players and regulatory approvals further enhance its growth potential. However, high costs and limited reimbursement in emerging economies pose moderate challenges.

Key Insights5 items

Competitive intensity remains moderate, with a mix of established players and niche innovators vying for market share through R&D investments and geographic expansion.

The long-term outlook is optimistic, supported by increasing adoption of normothermic perfusion systems and expanding applications in liver and heart transplants.

Innovation landscape is dynamic, with focus on biocompatible solutions, AI-integrated monitoring tools, and portable perfusion devices to address clinical gaps.

Demand–supply balance shows tension in high-income regions due to surging transplant needs, while supply chain bottlenecks for raw materials risk delaying production.

Key risk factors include stringent regulatory scrutiny, ethical debates around organ sourcing, and volatility in healthcare funding models.

In conclusion, the Organ Perfusion Solution market outlook highlights a resilient trajectory, but stakeholders must navigate evolving regulatory frameworks and invest in scalable, cost-effective solutions to sustain growth.

12 items

1. Executive Summary

2. Organ Perfusion Solution Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Organ Perfusion Solution Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Organ Perfusion Solution Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Organ Perfusion Solution Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Organ Perfusion Solution Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Organ Perfusion Solution Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Organ Perfusion Solution Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Organ Perfusion Solution Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Organ Perfusion Solution Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Organ Perfusion Solution Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Organ Perfusion Solution Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Organ Perfusion Solution Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Organ Perfusion Solution Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Organ Perfusion Solution Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Organ Perfusion Solution Market Competition by Key Manufacturers

9.1. Global Organ Perfusion Solution Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Organ Perfusion Solution: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Preservation Solutions, Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Organ Recovery Systems

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. XVIVO

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Global Transplant Solutions, Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Cardiolink

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Organ Perfusion Solution Market

Figure 4: Global Organ Perfusion Solution Market: Drivers

Figure 5: Global Organ Perfusion Solution Market: Challenges

Figure 6: Global Organ Perfusion Solution Market: Trends

Figure 7: Global Organ Perfusion Solution Market: Opportunity

Figure 8: Global Organ Perfusion Solution Market: Restraint

Figure 9: Global Organ Perfusion Solution Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Organ Perfusion Solution Market Value (USD Million) By Region

Figure 19: Global Organ Perfusion Solution Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Organ Perfusion Solution Market Value (USD Million) By Region

Figure 27: Global Organ Perfusion Solution Market Share (%) By: Regions (2032)

Figure 28: Global Organ Perfusion Solution Market Volume (K) By Region

Figure 29: Global Organ Perfusion Solution Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Organ Perfusion Solution Market Value (USD Million) By Region

Figure 37: Global Organ Perfusion Solution Market Share (%) By: Regions (2032)

Figure 38: Global Organ Perfusion Solution Market Volume (K) By Region

Figure 39: Global Organ Perfusion Solution Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

105 items

Table 1: Market Segmentation Analysis

Table 2: Global Organ Perfusion Solution Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Organ Perfusion Solution Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Organ Perfusion Solution Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Organ Perfusion Solution Market Value (USD Million) By Region

Table 14: Global Organ Perfusion Solution Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Organ Perfusion Solution Market Volume (K) By Region

Table 31: Global Organ Perfusion Solution Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Organ Perfusion Solution Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Organ Perfusion Solution Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Organ Perfusion Solution Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Preservation Solutions, Inc. Basic Information And Sales Area

Table 52: Preservation Solutions, Inc.. Products Portfolio

Table 53: Organ Recovery Systems Basic Information And Sales Area

Table 54: Organ Recovery Systems. Products Portfolio

Table 55: XVIVO Basic Information And Sales Area

Table 56: XVIVO. Products Portfolio

Table 57: Global Transplant Solutions, Inc. Basic Information And Sales Area

Table 58: Global Transplant Solutions, Inc.. Products Portfolio

Table 59: Cardiolink Basic Information And Sales Area

Table 60: Cardiolink. Products Portfolio

Table 61: Global Market Value (USD Million) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Market Value (USD Million) (2025-2032) By Types

Table 64: Global Market Share (%) By Types (2032)

Table 65: Global Market Volume (K) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Organ Perfusion Solution Market Value (USD Million) By Region

Table 70: Global Organ Perfusion Solution Market Share (%) By Region (2025-2032)

Table 71: North America Market Value (USD Million) (2025-2032) By Country

Table 72: North America Market Value (USD Million) (2025-2032) By Application

Table 73: North America Market Value (USD Million) (2025-2032) By Types

Table 74: Europe Market Value (USD Million) (2025-2032) By Country

Table 75: Europe Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Types

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 80: South America Market Value (USD Million) (2025-2032) By Country

Table 81: South America Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Types

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 86: Global Organ Perfusion Solution Market Volume (K) By Region

Table 87: Global Organ Perfusion Solution Market Share (%) By Region (2025-2032)

Table 88: North America Market Volume (K) (2025-2032) By Country

Table 89: North America Market Volume (K) (2025-2032) By Application

Table 90: North America Market Volume (K) (2025-2032) By Types

Table 91: Europe Market Volume (K) (2025-2032) By Country

Table 92: Europe Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Types

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 95: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 97: South America Market Volume (K) (2025-2032) By Country

Table 98: South America Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Types

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 101: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 103: Research Programs/Design For This Report

Table 104: Key Data Information From Secondary Sources

Table 105: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Organ Perfusion Solution Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Preservation Solutions, Inc.; Organ Recovery Systems; XVIVO; Global Transplant Solutions, Inc.; Cardiolink
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options